Global Industry Analysis, Size, Trends, and 2032 Forecast of the CRBSI Treatment Market
The introduction of effective treatment methods is being ensured through strict infection control protocols and the heightened awareness of healthcare professionals.
The catheter-related bloodstream infection (CRBSI) treatment market is expected to experience significant expansion due to the prevalence of chronic diseases and advancements in medical technology. CRBSI is a severe systemic infection that occurs when microorganisms enter the bloodstream through an indwelling catheter. Effective treatment requires timely interventions such as catheter removal, antibiotic administration, and supportive therapy. The global CRBSI treatment market is projected to grow at a CAGR of 5.66%, reaching an estimated value of $1.67 billion by 2025 and expanding further to $2.456 billion by 2032. Market growth is driven by increasing healthcare costs, technological advancements in catheter materials, and a heightened focus on infection control measures. Innovations such as antimicrobial coatings for catheters and smart monitoring technologies are enhancing treatment efficacy and patient safety.
- Company：データリソース
- Price：500,000 yen-1 million yen
